Skip to Main Content

Dr. Margaret Tempero is a gastrointestinal oncologist and the director of the UCSF Pancreas Center and leader of the Pancreas Cancer Program at the UCSF Helen Diller Family Comprehensive Cancer Center.

In research, Tempero was a pioneer in applying radioactively tagged antibodies for cancer therapy. She has led national research projects on gastrointestinal cancers, including pancreatic cancer.

Tempero has held editorial positions on such prestigious journals as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research and American Journal of Medicine. She is the Rombauer Family Distinguished Professor in Pancreas Cancer Clinical and Translational Science. Prior to joining UCSF, she was deputy director of the University of Nebraska's cancer center.

  • Education

    University of Nebraska School of Medicine, 1977

  • Residencies

    University of Nebraska Medical Center, Internal Medicine, 1980

  • Fellowships

    Memorial Sloan-Kettering Cancer, Hematology, 1981

    University of Nebraska Medical Center, Oncology, 1983

  • Board Certifications

    Hematology, American Board of Internal Medicine

    Medical Oncology, American Board of Internal Medicine

    Internal Medicine, American Board of Internal Medicine

  • Academic Title


Where I see patients (2)

    Selected research

    Decorative Caduceus

    Pancreatic Cancer Early Detection Consortium

    Diagnosis of PDAC


    Decorative Caduceus

    Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

    To determine the recommended phase II dose (RP2D) hydroxychloroquine in combination with trametinib.


    My work

    Stuart Rickerson: Pancreatic cancer patient
    Read on UCSF Health

    Doctor stories - Margaret Tempero

    Read on UCSF Health